Methodist Charlton Cancer Center

Dallas, Texas 75237

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Non-Small Cell Lung Cancer, Peripheral T-cell Lymphoma

Studies at this site

• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer — Stopped early
• A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma — Completed